Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 263

1.

Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/┬ÁL: A Stepped-Wedge, Cluster-Randomized Trial.

Meya DB, Kiragga AN, Nalintya E, Morawski BM, Rajasingham R, Park BJ, Mubiru A, Kaplan JE, Manabe YC, Boulware DR.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):182-189. doi: 10.1097/QAI.0000000000001894.

2.

Neurocognitive function in HIV-infected persons with asymptomatic cryptococcal antigenemia: a comparison of three prospective cohorts.

Montgomery MP, Nakasujja N, Morawski BM, Rajasingham R, Rhein J, Nalintya E, Williams DA, Huppler Hullsiek K, Kiragga A, Rolfes MA, Donahue Carlson R, Bahr NC, Birkenkamp KE, Manabe YC, Bohjanen PR, Kaplan JE, Kambugu A, Meya DB, Boulware DR; COAT and ORCAS Trial Teams.

BMC Neurol. 2017 Jun 12;17(1):110. doi: 10.1186/s12883-017-0878-2.

3.

Estimated Prevalence of Cryptococcus Antigenemia (CrAg) among HIV-Infected Adults with Advanced Immunosuppression in Namibia Justifies Routine Screening and Preemptive Treatment.

Sawadogo S, Makumbi B, Purfield A, Ndjavera C, Mutandi G, Maher A, Kaindjee-Tjituka F, Kaplan JE, Park BJ, Lowrance DW.

PLoS One. 2016 Oct 19;11(10):e0161830. doi: 10.1371/journal.pone.0161830. eCollection 2016.

4.

Implementation and Operational Research: Impact of Nurse-Targeted Care on HIV Outcomes Among Immunocompromised Persons: A Before-After Study in Uganda.

Kiragga AN, Nalintya E, Morawski BM, Kigozi J, Park BJ, Kaplan JE, Boulware DR, Meya DB, Manabe YC.

J Acquir Immune Defic Syndr. 2016 Jun 1;72(2):e32-6. doi: 10.1097/QAI.0000000000001002.

5.

Epidemiology of HIV-Associated Lung Disease in the United States.

Fitzpatrick M, Brooks JT, Kaplan JE.

Semin Respir Crit Care Med. 2016 Apr;37(2):181-98. doi: 10.1055/s-0036-1572556. Epub 2016 Mar 14. Review.

PMID:
26974297
6.

Scale-up of HIV Viral Load Monitoring--Seven Sub-Saharan African Countries.

Lecher S, Ellenberger D, Kim AA, Fonjungo PN, Agolory S, Borget MY, Broyles L, Carmona S, Chipungu G, De Cock KM, Deyde V, Downer M, Gupta S, Kaplan JE, Kiyaga C, Knight N, MacLeod W, Makumbi B, Muttai H, Mwangi C, Mwangi JW, Mwasekaga M, Ng'Ang'A LW, Pillay Y, Sarr A, Sawadogo S, Singer D, Stevens W, Toure CA, Nkengasong J.

MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1287-90. doi: 10.15585/mmwr.mm6446a3.

7.

Authors' Reply: Evidence-Based Programming of HIV Care and Support: Is the Psychosocial "Optional"?

Kaplan JE, Bateganya MH, Hamm TE, Langley C.

J Acquir Immune Defic Syndr. 2015 Dec 15;70(5):e178-9. doi: 10.1097/QAI.0000000000000840. No abstract available.

PMID:
26569180
8.

Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis.

Suthar AB, Vitoria MA, Nagata JM, Anglaret X, Mbori-Ngacha D, Sued O, Kaplan JE, Doherty MC.

Lancet HIV. 2015 Apr;2(4):e137-50. doi: 10.1016/S2352-3018(15)00005-3. Epub 2015 Mar 3. Review.

PMID:
26424674
9.

Postexposure Prophylaxis Against Human Immunodeficiency Virus (HIV): New Guidelines From the WHO: A Perspective.

Kaplan JE, Dominguez K, Jobarteh K, Spira TJ.

Clin Infect Dis. 2015 Jun 1;60 Suppl 3:S196-9. doi: 10.1093/cid/civ087. No abstract available.

PMID:
25972504
10.

Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature.

Kaplan JE, Vallabhaneni S, Smith RM, Chideya-Chihota S, Chehab J, Park B.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S331-9. doi: 10.1097/QAI.0000000000000484. Review.

PMID:
25768872
11.

Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.

Saadani Hassani A, Marston BJ, Kaplan JE.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S257-69. doi: 10.1097/QAI.0000000000000486. Review. Erratum in: J Acquir Immune Defic Syndr. 2015 Jun 1;69(2):e84.

12.

The impact of HIV care and support interventions on key outcomes in low- and middle-income countries: a literature review--introduction.

Kaplan JE, Hamm TE, Forhan S, Saadani Hassani A, Bang G, Weyant E, Tchuenche M, Langley C, Lapidos-Salaiz I, Bateganya MH.

J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3:S253-6. doi: 10.1097/QAI.0000000000000495. No abstract available.

13.

Incomplete adherence among treatment-experienced adults on antiretroviral therapy in Tanzania, Uganda and Zambia.

Denison JA, Koole O, Tsui S, Menten J, Torpey K, van Praag E, Mukadi YD, Colebunders R, Auld AF, Agolory S, Kaplan JE, Mulenga M, Kwesigabo GP, Wabwire-Mangen F, Bangsberg DR.

AIDS. 2015 Jan 28;29(3):361-71. doi: 10.1097/QAD.0000000000000543.

14.

Global epidemiology of HIV.

Fettig J, Swaminathan M, Murrill CS, Kaplan JE.

Infect Dis Clin North Am. 2014 Sep;28(3):323-37. doi: 10.1016/j.idc.2014.05.001. Review.

15.

Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America.

Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE; National Institutes of Health; Centers for Disease Control and Prevention; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2014 May;58(9):1308-11. doi: 10.1093/cid/ciu094. Epub 2014 Feb 27.

16.

Preventing malaria in HIV-infected pregnant women.

Bulterys PL, Kaplan JE, Gutman J.

Clin Infect Dis. 2014 Mar;58(5):660-2. doi: 10.1093/cid/cit805. Epub 2013 Dec 12. No abstract available.

PMID:
24336822
17.

Aspects of patient and clinician language predict adherence to antidepressant medication.

Kaplan JE, Keeley RD, Engel M, Emsermann C, Brody D.

J Am Board Fam Med. 2013 Jul-Aug;26(4):409-20. doi: 10.3122/jabfm.2013.04.120201.

18.

Developing WHO guidelines with pragmatic, structured, evidence-based processes: A case study.

Chang LW, Kennedy CE, Kennedy GE, Lindegren ML, Marston BJ, Kaplan JE, Sweat MD, Bunnell RE, O'Reilly K, Rutherford GW, Mermin JH.

Glob Public Health. 2010;5(4):395-412. doi: 10.1080/17441690903473253.

PMID:
20155547
19.
20.

Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America.

Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, Oleske JM, Currier JS, Gallant JE; HIV Medicine Association of the Infectious Diseases Society of America.

Clin Infect Dis. 2009 Sep 1;49(5):651-81. doi: 10.1086/605292.

PMID:
19640227

Supplemental Content

Loading ...
Support Center